Bio-Rad Announces Receipt of New Ruling in Applied Biosystems Patent Infringement Dispute
Bio-Rad Laboratories, Inc. announced that it is in receipt of a recommended ruling issued by the U.S. District Court for the District of Connecticut regarding the longstanding patent infringement dispute filed by Applera, on behalf of its Applied Biosystems group (ABI), against MJ Research, Inc. and the outstanding judgment against MJ Research. The Court has denied MJ Research's motion to enforce a settlement agreement established on August 29, 2005 among the parties. MJ Research and Bio-Rad plan to appeal this decision. In the interim, the company will continue to comply with the injunction issued by the Court on August 30, 2005.
This action is part of a patent infringement law suit relating to Polymerase Chain Reaction (PCR) and instruments (thermal cycler) for performing PCR. While Bio-Rad is a longtime licensee of certain intellectual property covered by Applera's patents, the company inherited responsibility for the 1998 patent infringement case brought against MJ Research as part of its August 2004 acquisition of MJ GeneWorks, Inc., the parent company of MJ Research.
Organizations
Other news from the department politics & laws

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Dental_braces

Researchers Find Warning Signs for Dementia in the Blood - Levels of Certain microRNAs Indicate Risk for Cognitive Decline

Gut microbiota and antibiotics: Missing puzzle piece discovered - HIRI scientists identify small RNA that influences the sensitivity of the intestinal pathogen Bacteroides thetaiotaomicron to certain antibiotics
Welichem Begins Patient Enrollment for Phase IIb Trial of WBI-1001 Creams in Patients with Atopic Dermatitis
Heptares enters a research and drug discovery collaboration with Juntendo University

FundaMental Pharma launches with EUR 10 million in Seed financing to advance a First-in-Class neuroprotectant - "These inhibitors have the potential to revolutionize therapies for currently untreatable neurodegenerative diseases"
Foot-and-mouth_disease

Bacterial protein structure could aid development of new antibiotics

Fountain of youth for ageing stem cells in bone marrow - Epigenetic changes in old age increase risk of osteoporosis and bone fractures
